Babak Mehrara, MD
Plastic and Reconstructive Surgery · New York, NYNPI 1437134426
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (34.8%), consulting fees and education — rather than concentrated in one kind of arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 20.9%. Reporting peaked in 2022 at $4,011 and has fallen 65.2% since, to $1,398 in 2025.
Across 44 payments — averaging $220.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tactile Systems Technology Inc$2K
- Pfizer$2K
- Surgical Innovation Associates, Inc.$2K
- RTI Surgical, Inc$1K
- Sientra, Inc.$854
- AbbVie$719
- plus $2K from 8 others
Across 7 payments — averaging $106,619 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$581K
- AbbVie$165K
What the payments were for
- Consulting fees$2,30024%
- Speaking & faculty fees$2,00021%
- Food & beverage$3,38235%
- Education$2,02521%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tactile Systems Technology Inc | 1 | $2,025 |
| Pfizer | 1 | $2,000 |
| Surgical Innovation Associates, Inc. | 1 | $1,500 |
| RTI Surgical, Inc | 3 | $1,093 |
| Sientra, Inc. | 7 | $854 |
| AbbVie(2 entities) | 14 | $719 |
| Integra Lifesciences Corporation | 8 | $659 |
| Axogen | 3 | $312 |
| Davol Inc. | 1 | $197 |
| Kerecis Limited | 1 | $151 |
| Avita Medical Americas, LLC | 1 | $108 |
| Motiva USA, LLC | 1 | $40 |
| Surgical Specialties Corporation (US), Inc. (dba Corza Medical) | 1 | $25 |
| Aroa Biosurgery Incorporated | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Flexitouch Plus$2,025
- ENTRE$2,025
- DuraSorb Monofilament Mesh$1,500
- CORTIVA ALLOGRAFT DERMIS$1,093
- Kerecis SurgiClose$605
- SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT$563
- ALLODERM$393
- TENOGLIDE$339
- ARISTA AH FLEXITIP$197
- Kerecis GraftGuide$151
- AVANCE NERVE GRAFT$124
- AxoGuard Nerve Connector$124
- AxoGuard Nerve Protector$124
- AXOGUARD HA+ NERVE PROTECTOR$124
- AxoGuard Nerve Cap$124
- SURGIMEND$121
- RECELL$108
How this compares
$9,707 in reported general payments places this provider in the 80th percentile of 219 plastic and reconstructive surgery providers in New York.
See all plastic and reconstructive surgery providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other plastic and reconstructive surgery in New York
- Robert GrantNew York$207K
- Christine RohdeNew York$180K
- Steven LevineNew York$108K
- Theodore DiktabanNew York$83K
- Lawrence BassNew York$37K
- Nicholas BastidasNew York$27K
- Philip MillerNew York$24K
- Joseph DisaNew York$21K
- Graham SchwarzNew York$16K
- Evan MatrosNew York$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.